Revolution Medicines, Inc. (RVMD)
117.53
+1.31
(+1.13%)
USD |
NASDAQ |
Jan 21, 16:00
115.05
-2.48
(-2.11%)
After-Hours: 20:00
Revolution Medicines Research and Development Expense (Annual): 584.60M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Merck & Co., Inc. | 15.79B |
| AbbVie, Inc. | 8.315B |
| Eli Lilly & Co. | 10.99B |
| Disc Medicine, Inc. | 96.52M |
| Solid Biosciences, Inc. | 96.43M |